Genetic–Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies
Epigenomes · 10.02.2026 · 10 (1) · 10
DOI: 10.3390/epigenomes10010010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epigenomes, online erschienen am 10.02.2026. Verfasst von Andra-Giorgiana Zaruha und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy Carol Davila.
Abstract (Originalsprache)
Epilepsy is a heterogeneous neurological disorder with a strong genetic basis, yet recent evidence underscores the critical role of epigenetic mechanisms in its pathogenesis. This review synthesizes current knowledge on how chromatin remodeling, histone modifications, DNA methylation, and transcriptional regulation intersect with classical channelopathies and signaling pathways. We emphasize how epigenetic dysregulation contributes to neuronal excitability and network plasticity, particularly through interactions with mTOR, PI3K-AKT, and GABAergic signaling cascades. The convergence of genetic mutations and epigenetic modifications creates a dynamic landscape in which environmental factors can modify gene expression and contribute to the development of epilepsy. Emerging therapeutic strategies—including epigenetic drugs (HDAC inhibitors, DNMT inhibitors), CRISPR/dCas9-based epigenome editing, and multi-omics approaches—offer promising avenues for precision medicine. This review provides a comprehensive synthesis of genetic and epigenetic mechanisms in epilepsy, examining how these layers interact to produce disease phenotypes and discussing the therapeutic implications of this multilayered regulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Pediatric Neurology Department, Prof. Dr. Alex. Obregia Clinical Hospital of Psychiatry, 041914 Bucharest, Romania.
- Pediatric Neurology Department, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Genetics, Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania.
- "Alessandrescu-Rusescu" National Institute for Maternal and Child Health, 20382 Bucharest, Romania.
ORCID-Profile: Monica Andreea Novac Ii, Diana Bârcă
Förderung
- University of Medicine and Pharmacy Carol Davila
Zitieren
APA
Zaruha, A. G., Codreanu, P., Coman, M. C., Novac Ii, M. A., Duță-Ion, S. G., Jugănaru, I. R., Hotinceanu, I. A., Dan, A., Burtavel, L. M., Eftenoiu, A. E., Bârcă, D., Ionescu, A., Paraschiv, C., & Rădoi, V. E. (2026). Genetic–Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies. Epigenomes, 10(1), 10. https://doi.org/10.3390/epigenomes10010010
Vancouver
Zaruha AG, Codreanu P, Coman MC, Novac Ii MA, Duță-Ion SG, Jugănaru IR, et al. Genetic–Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies. Epigenomes. 2026;10(1):10. doi:10.3390/epigenomes10010010
BibTeX
@article{Zaruha2026,
author = {Zaruha, Andra-Giorgiana and Codreanu, Patricia and Coman, Mădălin-Codruț and Novac Ii, Monica Andreea and Duță-Ion, Simona Gabriela and Jugănaru, Ioana Ruxandra and Hotinceanu, Iulian Andrei and Dan, Andra and Burtavel, Livia Mălina and Eftenoiu, Anca-Elena and Bârcă, Diana and Ionescu, Andreea and Paraschiv, Cerasela and Rădoi, Viorica-Elena},
title = {Genetic–Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies},
journal = {Epigenomes},
year = {2026},
volume = {10},
number = {1},
pages = {10},
doi = {10.3390/epigenomes10010010}
}
EUVIMED